U.S. Consumer Services Stock News

In Q4 2025, Teekay Corp Ltd reported strong net income and free cash flow while advancing its fleet renewal by acquiring newer Aframax tankers and selling older vessels, and it maintained a regular fixed dividend to return capital to shareholders. An interesting aspect of this update is Teekay’s combination of a younger, more efficient fleet and a debt‑free balance sheet at Teekay Tankers, which reduces its free cash flow breakeven and increases flexibility amid shifting, sanction‑affected...

MasterBrand (MBC) is back in focus after reporting a fourth quarter net loss of US$42 million on sales of US$644.6 million, alongside guidance calling for a year over year sales decline. See our latest analysis for MasterBrand. The earnings miss and softer 2026 guidance appear to have cooled sentiment, with an 8.35% 1 month share price return decline and a 19.44% 1 year total shareholder return loss, despite an 11.20% 3 month share price return gain. If this kind of earnings driven volatility...

Why Sarepta Therapeutics (SRPT) is on investors’ radar Sarepta Therapeutics (SRPT) has drawn attention after a turbulent stretch for shareholders, with the stock showing an 82.2% negative total return over the past year and 84.7% over the past 3 years. At a last close of US$18.88, the company’s recent month performance reflects a 10.6% decline, while the past 3 months are roughly flat with a 0.2% negative return. This has prompted questions about how its rare disease franchise is currently...

Alight, Inc. reported fourth-quarter 2025 results showing sales of US$653 million versus US$680 million a year earlier, alongside a goodwill impairment charge of US$803 million that contributed to a full-year net loss of US$3.10 billion. The company is halting its dividend, increasing investment in AI and operational improvements, and has reshaped senior leadership in key Health, Navigation and Leaves solutions while simultaneously completing a sizeable share repurchase program. Next, we...

Select Medical Holdings (SEM) has been drawing attention after recent share moves, with the stock down about 7% over the past week and 13.6% over the past year, despite reports of positive annual revenue and net income growth. See our latest analysis for Select Medical Holdings. The recent 1 day share price return of a 6.65% decline and 7 day share price return of an 8.36% decline suggest momentum has cooled, even though the 90 day share price return of 7.14% and 3 year total shareholder...

NNN REIT (NNN) is back in focus after a boardroom shift, with longtime chair Steven D. Cosler retiring and independent director Edward J. Fritsch stepping in as the new Chair on February 18, 2026. See our latest analysis for NNN REIT. The leadership change comes as NNN REIT’s share price, now at $44.35, has recorded a 4.95% 1 month share price return and 8.57% 3 month share price return, while its 1 year total shareholder return sits at 13.55%. This points to gradually building momentum...

If you are wondering whether Netflix's current share price reflects its long term potential or is baking in too much optimism, it helps to break the story down into hard numbers and valuation checks. The stock last closed at US$78.67, with returns of 2.3% over 7 days, an 8.7% decline over 30 days, a 13.5% decline year to date, a 21.6% decline over 1 year and gains of 148.1% over 3 years and 46.0% over 5 years. Recent coverage has focused on Netflix's ongoing push in content, international...

If you are wondering whether UnitedHealth Group's current share price reflects its underlying worth, you are not alone. This article is set up to help you unpack that question clearly. The stock last closed at US$290, with returns of a 1.1% decline over 7 days, an 18.6% decline over 30 days, a 13.8% decline year to date and a 36.3% decline over 1 year, adding important context for anyone reassessing risk and potential reward. Recent coverage has focused on UnitedHealth Group's role in the...

In February 2026, Tata Consultancy Services’ HyperVault subsidiary and AMD expanded their collaboration to co-develop “Helios,” a rack-scale AI infrastructure design for India’s national AI initiatives, built around AMD’s Instinct MI455X GPUs, next-generation EPYC “Venice” CPUs, Pensando Vulcano NICs and ROCm software. This AI-ready data center blueprint, supporting up to 200 MW per site and aimed at sovereign AI factories, deepens AMD’s role in large-scale infrastructure projects and could...

In February 2026, Mubadala Energy announced it had awarded SLB multiple integrated offshore drilling services contracts for the Tangkulo deepwater gas development and related wells in Indonesia’s Andaman Sea, while Equinor and Star Energy Geothermal also selected SLB for subsea compression upgrades and geothermal drilling support. Together, these wins underscore how SLB’s integrated drilling, subsea compression and geothermal capabilities are being applied across both conventional gas and...

In early February 2026, H&R Block announced a suite of enhancements to its tax preparation services, including AI Tax Assist for 24/7 client support, advanced AI tools for tax professionals, a Smart Product Selector for DIY tier selection, and upgraded technology to help filers locate forms and optimize deductions. This push to blend AI-powered automation with human expertise could reshape how clients interact with H&R Block’s omnichannel tax offerings during the core filing season. Next,...

American States Water (AWR) just paired its latest earnings release with an approved dividend increase and new California rate hikes, a mix that puts both its income profile and regulated utility cash flows in focus. See our latest analysis for American States Water. Even with the dividend increase and new California rate hikes, American States Water’s share price performance has been fairly subdued. The 7 day share price return shows a 2.6% decline and the year to date share price return is...

Boyd Gaming Corporation recently increased its quarterly dividend to US$0.20 per share from US$0.18, payable on April 15, 2026, to shareholders of record on March 16, 2026, reinforcing its pattern of returning cash to investors. This fourth consecutive dividend hike, alongside record earnings, balance sheet strengthening, and ongoing online and property investments, highlights management’s emphasis on combining growth projects with regular cash distributions. We’ll now examine how Boyd...

Online used car auction platform ACV Auctions recently reported earnings after the bell, following a prior quarter where it met revenue expectations but missed its full-year revenue and EBITDA guidance. This latest update comes as the company heads into a period of slower expected revenue growth and heightened scrutiny of how it manages a tougher used-vehicle market and the fallout from a former customer bankruptcy. Next, we’ll examine how ACV’s adjusted revenue guidance amid a challenging...

CRISPR Therapeutics AG reported fourth-quarter 2025 revenue of US$864,000 and a net loss of US$130.61 million, with full-year 2025 revenue of US$3.51 million and a net loss of US$581.6 million. Against these weaker financial results, investor attention has shifted to the advancing gene-editing pipeline, including zugo-cel’s FDA Regenerative Medicine Advanced Therapy designation and growing Casgevy commercialization. We’ll now examine how the FDA’s RMAT designation for zugo-cel shapes CRISPR...

On February 12, 2026, CareDx announced pivotal clinical validation results for AlloHeme, an NGS- and AI-powered blood test that detects emerging relapse in AML and MDS patients after allogeneic transplant significantly earlier than traditional bone marrow or marker-specific methods, based on data from the 198-patient ACROBAT study. The successful validation of AlloHeme marks a key step in extending CareDx’s transplant-focused precision medicine platform into hematology and oncology,...

In February 2026, Coty withdrew its fiscal 2026 guidance after fiscal second-quarter results came in below plan under newly appointed interim CEO Markus Strobel. This combination of weaker-than-expected results and reduced visibility under new leadership has prompted analysts to re-evaluate Coty’s longer-term outlook and risk profile. We’ll now explore how the withdrawal of FY26 guidance under interim leadership could influence Coty’s existing investment narrative. Invest in the nuclear...

Stifel Financial (SF) is back on investors’ radar after recent share price moves, with the stock showing mixed returns over the past month and past 3 months alongside double digit 1 year and multi year total returns. See our latest analysis for Stifel Financial. With the share price at US$119.91, Stifel Financial’s recent 6.5% decline in the 1 month share price return contrasts with its stronger 1 year and multi year total shareholder returns. This suggests earlier optimism is now being...

If you are wondering whether CRH is still reasonably priced after a strong run, this article walks through what the current share price could imply about its underlying value. The stock trades at US$124.04, with returns of 1.0% over 30 days, a 1.5% decline over 7 days, a 1.9% decline year to date, 25.0% over 1 year, 182.5% over 3 years and 210.7% over 5 years on a trailing basis. Recent headlines around CRH have focused on its position as a major building materials group and ongoing interest...

Kennametal recently reported fiscal Q2 2026 results that exceeded analyst expectations on earnings per share and revenue, driven by strength in its aerospace and defense business while it continues to manage rising tungsten costs. At the same time, insider activity, including stock sales by Vice President John Wayne Witt and option exercises by Board Member William Lambert, adds an extra layer of context for investors assessing management’s confidence and capital allocation...

Clorox (NYSE:CLX) has agreed to acquire GOJO Industries, the maker of Purell hand sanitizer, expanding its presence in health and hygiene products. The company has also released its "Home Care Redefined" report, outlining how it is thinking about wellness focused consumer needs in home care. These moves point to a more concentrated push into health, hygiene, and consumer wellness offerings across Clorox's portfolio. Clorox, trading at $123.6, sits at an interesting point for investors...

The U.S. Supreme Court recently struck down tariffs imposed by the Trump administration, a move expected to lower costs for manufacturers and logistics providers that rely on imported parts, materials, and equipment. For Old Dominion Freight Line, reduced tariff-related input costs could help cushion the impact of softer freight volumes and support its emphasis on service quality and efficiency. We’ll now examine how this tariff ruling, and its potential to lower operating costs, interacts...

Ares Management (ARES) has priced its second European Direct Lending Collateralized Loan Obligation, Ares European Direct Lending CLO II, at over €300 million, drawing attention to the stock as investors assess what this new vehicle might mean. See our latest analysis for Ares Management. The EDL CLO II launch lands at a time when Ares Management’s 1 day share price return of 5.15% and 30 day share price return of 21% sit against a 1 year total shareholder return decline of 27.3%, even though...

Amicus Therapeutics (FOLD) closed out FY 2025 with Q4 revenue of US$185.2 million and basic EPS of US$0.01, alongside net income excluding extra items of US$1.7 million, giving investors fresh data on how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$149.7 million in Q4 2024 to US$185.2 million in Q4 2025, while basic EPS shifted from US$0.05 to US$0.01 over the same period, creating a mixed picture on profitability trends. With...